ES2113354T3 - Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina. - Google Patents
Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina.Info
- Publication number
- ES2113354T3 ES2113354T3 ES91106224T ES91106224T ES2113354T3 ES 2113354 T3 ES2113354 T3 ES 2113354T3 ES 91106224 T ES91106224 T ES 91106224T ES 91106224 T ES91106224 T ES 91106224T ES 2113354 T3 ES2113354 T3 ES 2113354T3
- Authority
- ES
- Spain
- Prior art keywords
- proteins
- polypeptides
- somatotropins
- cysteine
- stabilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000018102 proteins Nutrition 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title 1
- 235000018417 cysteine Nutrition 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
- 239000002699 waste material Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A POLIPEPTIDOS Y PROTEINAS DE HUMANOS Y MAMIFEROS NATURALES Y RECOMBINANTES DERIVADOS FISIOLOGICAMENTE ACTIVOS. LA INVENCION CONSISTE EN METODOS QUIMICOS PARA DERIVAR POLIPEPTIDOS O PROTEINAS RECOMBINANTEMENTE DERIVADOS QUE CONTIENE RESIDUOS DE CISTEINA, BIEN NATURALMENTE O A TRAVES DE MUTAGENESIS ESPECIFICA LOCAL. LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHAS PROTEINAS DERVIADAS Y/O POLIPEPTIDOS ESTAN FORMULADAS PARA SER COMPOSICIONES ESTABLES Y DE LARGA ACTIVIDAD DE DICHAS PROTEINAS Y/O POLIPEPTIDOS, QUE ANTES ERAN DIFICIL DE CONSEGUIR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51904790A | 1990-05-04 | 1990-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2113354T3 true ES2113354T3 (es) | 1998-05-01 |
Family
ID=24066559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91106224T Expired - Lifetime ES2113354T3 (es) | 1990-05-04 | 1991-04-18 | Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0458064B1 (es) |
JP (1) | JPH069696A (es) |
KR (1) | KR100213455B1 (es) |
AT (1) | ATE163431T1 (es) |
AU (1) | AU639324B2 (es) |
CA (1) | CA2041742A1 (es) |
DE (1) | DE69128944T2 (es) |
DK (1) | DK0458064T3 (es) |
ES (1) | ES2113354T3 (es) |
FI (1) | FI912144A (es) |
GR (1) | GR3026436T3 (es) |
IE (1) | IE911511A1 (es) |
IL (1) | IL97932A (es) |
NO (1) | NO911752L (es) |
NZ (1) | NZ237959A (es) |
PT (1) | PT97539B (es) |
ZA (1) | ZA913359B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
GB9100381D0 (en) * | 1991-01-09 | 1991-02-20 | Erba Carlo Spa | Human bfgf derivatives,their analogs and process for their production |
AU2147192A (en) * | 1991-06-28 | 1993-01-25 | Genentech Inc. | Method of stimulating immune response using growth hormone |
US5336488A (en) * | 1991-08-07 | 1994-08-09 | American Cyanamid Company | Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
JP2704214B2 (ja) * | 1991-12-10 | 1998-01-26 | タノックス バイオシステムズ インコーポレイテッド | 非対合システイン残基を有するサイトカイン及びその結合体 |
AU6048294A (en) * | 1992-11-25 | 1994-06-22 | Amgen Boulder Inc. | Modified insulin-like growth factors |
EP0622394A1 (en) * | 1993-04-30 | 1994-11-02 | S.A. Laboratoires S.M.B. | Reversible modification of sulfur-containing molecules with polyalkylene glycol derivatives and their use |
IL133974A0 (en) | 1997-07-14 | 2001-04-30 | Bolder Biotechnology Inc | Derivatives of growth hormone and related proteins |
WO2001087925A2 (en) | 2000-05-16 | 2001-11-22 | Bolder Biotechnology, Inc. | Methods for refolding proteins containing free cysteine residues |
US7153943B2 (en) | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
US7270809B2 (en) | 1997-07-14 | 2007-09-18 | Bolder Biotechnology, Inc. | Cysteine variants of alpha interferon-2 |
US7495087B2 (en) | 1997-07-14 | 2009-02-24 | Bolder Biotechnology, Inc. | Cysteine muteins in the C-D loop of human interleukin-11 |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
AU2008202371B2 (en) * | 1999-01-14 | 2012-08-02 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
JP2004524020A (ja) * | 2001-01-11 | 2004-08-12 | マキシゲン・エイピーエス | 改良された成長ホルモン分子 |
AP2004003050A0 (en) * | 2001-11-20 | 2004-06-30 | Pharmacia Corp | Chemically modified human growth hormone conjugates |
KR101238517B1 (ko) | 2002-12-26 | 2013-02-28 | 마운틴 뷰 파마슈티컬즈, 인크. | 생물학적 효능이 향상된 인터페론-베타의 중합체 접합체 |
CN100580087C (zh) * | 2003-10-10 | 2010-01-13 | 诺和诺德医疗保健公司 | 肽的缀合 |
US7524813B2 (en) | 2003-10-10 | 2009-04-28 | Novo Nordisk Health Care Ag | Selectively conjugated peptides and methods of making the same |
WO2007041614A2 (en) | 2005-10-03 | 2007-04-12 | Bolder Biotechnology, Inc. | Long acting vegf inhibitors and methods of use |
US8617531B2 (en) | 2006-12-14 | 2013-12-31 | Bolder Biotechnology, Inc. | Methods of making proteins and peptides containing a single free cysteine |
MX345736B (es) * | 2010-01-22 | 2017-02-14 | Novo Nordisk Healthcare Ag | Hormonas de crecimiento con eficacia in vivo prolongada. |
JP6464145B2 (ja) | 2013-04-05 | 2019-02-06 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 成長ホルモン化合物製剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
DE68929273T2 (de) * | 1988-08-24 | 2001-07-05 | American Cyanamid Co | Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
-
1991
- 1991-04-18 EP EP91106224A patent/EP0458064B1/en not_active Expired - Lifetime
- 1991-04-18 DE DE69128944T patent/DE69128944T2/de not_active Expired - Fee Related
- 1991-04-18 ES ES91106224T patent/ES2113354T3/es not_active Expired - Lifetime
- 1991-04-18 DK DK91106224.8T patent/DK0458064T3/da active
- 1991-04-18 AT AT91106224T patent/ATE163431T1/de not_active IP Right Cessation
- 1991-04-24 IL IL97932A patent/IL97932A/en not_active IP Right Cessation
- 1991-04-26 NZ NZ237959A patent/NZ237959A/en unknown
- 1991-04-29 AU AU76075/91A patent/AU639324B2/en not_active Ceased
- 1991-05-02 PT PT97539A patent/PT97539B/pt not_active IP Right Cessation
- 1991-05-02 CA CA002041742A patent/CA2041742A1/en not_active Abandoned
- 1991-05-02 JP JP3128190A patent/JPH069696A/ja active Pending
- 1991-05-03 FI FI912144A patent/FI912144A/fi not_active Application Discontinuation
- 1991-05-03 NO NO91911752A patent/NO911752L/no unknown
- 1991-05-03 ZA ZA913359A patent/ZA913359B/xx unknown
- 1991-05-03 KR KR1019910007216A patent/KR100213455B1/ko not_active IP Right Cessation
- 1991-05-03 IE IE151191A patent/IE911511A1/en not_active Application Discontinuation
-
1998
- 1998-03-24 GR GR970403459T patent/GR3026436T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ZA913359B (en) | 1992-03-25 |
NZ237959A (en) | 1994-05-26 |
EP0458064A2 (en) | 1991-11-27 |
DE69128944T2 (de) | 1998-06-25 |
NO911752D0 (no) | 1991-05-03 |
AU7607591A (en) | 1991-11-07 |
KR910020032A (ko) | 1991-12-19 |
AU639324B2 (en) | 1993-07-22 |
DK0458064T3 (da) | 1998-04-27 |
EP0458064B1 (en) | 1998-02-25 |
EP0458064A3 (en) | 1992-06-17 |
PT97539A (pt) | 1992-02-28 |
NO911752L (no) | 1991-11-05 |
CA2041742A1 (en) | 1991-11-05 |
PT97539B (pt) | 1998-08-31 |
KR100213455B1 (ko) | 1999-08-02 |
ATE163431T1 (de) | 1998-03-15 |
JPH069696A (ja) | 1994-01-18 |
IE911511A1 (en) | 1991-11-06 |
IL97932A0 (en) | 1992-06-21 |
DE69128944D1 (de) | 1998-04-02 |
FI912144A0 (fi) | 1991-05-03 |
GR3026436T3 (en) | 1998-06-30 |
IL97932A (en) | 1998-02-22 |
FI912144A (fi) | 1991-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2113354T3 (es) | Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina. | |
DE69027989D1 (de) | Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON | |
DE3675083D1 (de) | Material zum ausfuellen von periodontalen knochendefekten. | |
ATE93238T1 (de) | Menschliche insulinanalage und zubereitungen daraus. | |
AU4020289A (en) | Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis of chemical derivatization | |
ATE119941T1 (de) | Subtilisin-analoge. | |
DK393288A (da) | Praeparat til saarheling og knogleregenerering | |
DE68909139T2 (de) | Substanz FR901228 und deren Herstellung. | |
FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
DE3751269T2 (de) | Expression des biologisch aktiven Faktors XIII. | |
NO932148L (no) | Fusjonspolypeptider | |
ES2124308T3 (es) | Composicion estable de polipeptidos. | |
MX9203175A (es) | Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion. | |
DK0533408T3 (da) | Kosmetik og farmaceutika indeholdende extensiner | |
SE8200757L (sv) | Biologiskt aktiva peptider | |
DE3667472D1 (de) | Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen. | |
ES2079539T3 (es) | Inhibidores de la captacion de calcio. | |
DE59008844D1 (de) | Benzylselenobenzamide von Aminopyridinen und Picolylaminen. | |
NO873751L (no) | Lymfocytt-aktiverende polypeptider. | |
IT8321445A1 (it) | Processo ed impianto per l'ottenimento di frazioni liquide pregiate, gas combustibile, calcare e/o ossido di calcio da rocce bituminose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 458064 Country of ref document: ES |